An update on topical therapies for mild-moderate psoriasis.

Peter C M van de Kerkhof

Journal: Dermatologic clinics 2015;33(1):73-7

PMID: 25412784

Full Text on Elsevier Science View on PubMed

Abstract

Topical therapies are the mainstream treatment of psoriasis because most patients have mild disease. First-line treatments are vitamin D derivatives and corticosteroids. These treatments are usually given in combination schedules. For topical treatments the selection of the most appropriate vehicle is of major importance, thus improving adherence to the treatment, which frequently is impaired by the complexities of topical therapeutic choices. Evidence for efficacy and safety of topical treatments is readily available for vitamin D treatments and short-term treatment with corticosteroids. However, the scientific evidence for longer-term treatments is limited. Multiple new small molecules are in various stages of development and are reviewed.

Address: Department of Dermatology, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500HB, The Netherlands. Electronic address: [email protected].

DOI: 10.1016/j.det.2014.09.006

Link outs

Free resources

Medical:

https://medlineplus.gov/psoriasis.html

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Subscription / membership required

Full Text Sources:

MeSH Terms: Administration, Cutaneous, Adrenal Cortex Hormones, Anthralin, Anti-Inflammatory Agents, Cholecalciferol, Coal Tar, Dermatologic Agents, Drug Therapy, Combination, Humans, Protein Kinase Inhibitors, Psoriasis, Retinoids, Severity of Illness Index, Vitamins